Pneumatic Lymphatic Drainage

Uses

How it works

Dosage & preparation

Evidence quality

Highlighted claims

• Participants assigned to PLD use the device from the day of surgery until Day 183 in addition to standard postoperative care. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial
• Participants are instructed to use PLD for at least 60 minutes daily while resting supine. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial
• The investigational PLD system is designed to provide anatomically directed mechanical stimulation aligned with physiological lymphatic pathways. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial
• The PLD device allows separate pressure settings for foot, lower leg, thigh, and trunk within a 20-60 mm Hg range. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial
• Clinical efficacy of PLD after LVA had not previously been tested in a randomized controlled trial. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial
• Earlier exploratory lymphoscintigraphy studies suggested PLD could facilitate tracer transport under low-pressure conditions without serious device-related adverse events in mild lower extremity lymphoedema. — Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trial